Dr. Irma Zamudio Featured as Speaker at Roche Press Day 2025
Dr. Zamudio highlighted the impact of diabetes in Mexico and the need for preventive care to reduce diabetic blindness.
Dr. Irma Miriam Zamudio, ophthalmologist at CODET Vision Institute, participated as a speaker at the prestigious Roche Press Day 2025, where she presented her talk titled: “Current Landscape of Retinal Diseases: Challenges and Opportunities in Health Institutions.”
During her talk, Dr. Zamudio discussed the prevalence of diabetes in Mexico and its significant impact on patients’ visual health. She highlighted the challenges hospitals and healthcare systems face in diagnosing and treating retinal diseases caused by diabetes and emphasized the need to shift from a reactive, treatment-based model to a preventive approach in managing this condition.
About Roche and the Roche Press Day
Roche is a global healthcare company dedicated to advancing pharmaceutical research and diagnostic innovation. Its mission is to enable more personalized and effective medicine.
Roche Press Day is an annual event where Roche brings together health leaders, specialists, and media across Latin America to share discoveries, clinical studies, medical innovations, and emerging healthcare challenges. Participation in this forum allows professionals to exchange insights that help improve patient outcomes and promote innovation in healthcare.
Diabetes in Mexico: A Key Factor in Retinal Health
Many retinal diseases, such as diabetic retinopathy, arise from complications of uncontrolled diabetes. Diabetic retinopathy remains the leading cause of irreversible blindness among working-age adults in Mexico.
- According to recent data, 40.2% of people with diabetes in Mexico have some degree of diabetic retinopathy, and 19.9% suffer from diabetic macular edema. Understanding the current state of diabetes in Mexico is crucial to protecting vision.
- The Mexican Diabetes Federation (FMD) estimates that around 500 million people worldwide are currently living with diabetes — yet only 1 in 2 individuals have been properly diagnosed.
Dr. Zamudio emphasized the importance of referring patients with diabetes for ophthalmologic evaluation. Early detection at any level of care can make a life-changing difference in preventing blindness.
- According to Mexico’s Epidemiological Surveillance System for Type 2 Diabetes Mellitus (2024), 55% of patients with type 2 diabetes have never had an eye exam — a concerning reality that prevents timely detection and treatment of retinal complications.
These statistics reveal that a large portion of Mexico’s population is at risk of developing serious complications, including retinal damage and vision loss. Maintaining proper blood glucose control through a healthy diet, regular exercise, and consistent medical supervision is essential to prevent these outcomes.
Our Commitment at CODET
We are proud to see members of our medical team like Dr. Zamudio sharing their expertise on international platforms such as Roche Press Day 2025. Her participation highlights not only her leadership but also CODET Vision Institute’s ongoing commitment to excellence, education, and innovation in eye care.
If you have diabetes or are at risk, don’t wait until symptoms appear — schedule your eye exam today. At CODET, we believe that seeing better means living better.